Model
Edge
Kinnate BioPharma Inc.
KNTE
Filing type
8-K
Filing date
Jan 15, 2024
Updated
Jan 16, 2024 ยท 9:05 AM
Copy reference
Filing
8-K
Notice of Exempt Offering of Securities